Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

Vitamin B3, Niacinamide, Nicotinic acid, Niacin

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

21 API Suppliers, 9 USDMF, 3 CEP/COS, 3 EU WC, 2 KDMF, 4 NDC API, 12 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

28 Drugs in Development

28 Drugs in Development

FINISHED DOSAGE FORMULATIONS

100 FDF Dossiers, 60 FDA Orange Book, 16 Europe, 1 Canada, 2 South Africa, 21 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - 1GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 750MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Minakem, 3 Evonik, 13 Rochem International Inc, 23 SPI Pharma, 21 DKSH, 2 Pharm-RX Chemical, 6 Boai NKY Pharmaceuticals Ltd, 8 Gangwal Healthcare, 10 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 2 Pfanstiehl, 20 Kirsch Pharma, 4 ACG Worldwide, 11 Actylis, 2 Aeon Procare, 1 Alcedo Pharmachem, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 36 BASF, 1 Bioplus Life Sciences, 4 CD Formulation, 2 Clariant, 15 Corel Pharma Chem, 5 DFE Pharma, 1 Esteem Industries, 2 Finar, 13 Gangwal Chemicals, 9 Ideal Cures, 4 Ingredion Pharma Solutions, 22 Kerry, 3 Keval Exports, 5 Kima Chemical, 6 Lonza Capsugel, 19 Microlex e.U, 1 Nanjing Bold Chemical, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 3 Novo Excipients, 3 Pharmatrans-Sanaq, 11 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 35 Roquette, 17 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 3 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 3 Silverline Chemicals, 4 The Dow Chemical Company, 2 Ulanqab Kema New Material, 2 Valens Pharmachem, 3 Vasa Pharmachem, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

97 Fillers, Diluents & Binders, 71 Coating Systems & Additives, 58 Thickeners and Stabilizers, 46 Parenteral, 42 Solubilizers, 40 Controlled & Modified Release, 40 Taste Masking, 38 Direct Compression, 33 Topical, 33 Granulation, 29 Film Formers & Plasticizers, 27 Lubricants & Glidants, 25 Disintegrants & Superdisintegrants, 24 Chewable & Orodispersible Aids, 17 Rheology Modifiers, 16 Co-Processed Excipients, 14 Emulsifying Agents, 10 API Stability Enhancers, 9 Empty Capsules, 9 Surfactant & Foaming Agents, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

DIGITAL CONTENT

17 News #PharmaBuzz

17 News #PharmaBuzz

GLOBAL SALES INFORMATION

10 US Medicaid Prescriptions, 11 Regulatory FDF Prices

MARKET PLACE

18 APIs, 1 Intermediates

PATENTS & EXCLUSIVITIES

24 Health Canada Patents

24 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 1 USP, 2 JP, 5 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	Registration No.	Compound	Registration Date	Manufacturer	Manufacturer's Country	Manufacturer's Address
29/11/2025	Amsal Chem Private Ltd.	India	Toru Co., Ltd.	20250324-211-J-1755	Niacin	2025-03-24	Amsal Chem. Pvt. Ltd.	India	A1-401-402-403, GIDC, Ankleshwar-393002, District Bharuch, Gujarat, India.
29/11/2025	Divis Laboratories	India	Pharmaline Co., Ltd.	20250414-211-J-1833	Niacin	2025-04-14	DIVI'S LABORATORIES LIMITED	India	UNIT-1, Lingojigudem Village Choutuppal Mandal Yadadri Bhuvanagiri District Telangana– 508252 INDIA

Vitamin B3, Niacinamide, Nicotinic Acid, Niacin

Vitamin B3, Niacinamide, Nicotinic acid, Niacin

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

21 API Suppliers

9 USDMF

3 CEP/COS

3 EU WC

2 KDMF

4 NDC API

12 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

28 Drugs in Development

FINISHED DOSAGE FORMULATIONS

100 FDF Dossiers

60 FDA Orange Book

16 Europe

1 Canada

2 South Africa

21 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - 1GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 750MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI

1 Minakem

3 Evonik

13 Rochem International Inc

23 SPI Pharma

21 DKSH

2 Pharm-RX Chemical

6 Boai NKY Pharmaceuticals Ltd

8 Gangwal Healthcare

10 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

2 Pfanstiehl

20 Kirsch Pharma

4 ACG Worldwide

11 Actylis

2 Aeon Procare

1 Alcedo Pharmachem

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ashland

36 BASF

1 Bioplus Life Sciences

4 CD Formulation

2 Clariant

15 Corel Pharma Chem

5 DFE Pharma

1 Esteem Industries

2 Finar

13 Gangwal Chemicals

9 Ideal Cures

4 Ingredion Pharma Solutions

22 Kerry

3 Keval Exports

5 Kima Chemical

6 Lonza Capsugel

19 Microlex e.U

1 Nanjing Bold Chemical

3 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

3 Novo Excipients

3 Pharmatrans-Sanaq

11 Pluviaendo

3 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

35 Roquette

17 Seppic

7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

3 Shijiazhuang Huaxu Pharmaceutical

10 Sigachi Industries

3 Silverline Chemicals

TABLET, EXTENDED RELEASE;ORAL - 1GM Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 500MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 750MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons